Gefitinib tablets 250mg “Sandoz,” manufactured by Daito (YJ code: 4291013F1078, standard: 250mg x 1 tablet), contain gefitinib, indicated for metastatic non-small cell lung cancer in patients with specific epidermal growth factor receptor (EGFR) mutations.
Gefitinib tablets 250mg “Sandoz”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
